Xenetic Biosciences, Inc. (XBIO) Financials

XBIO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.0 million 1.1 million
2023-06-30 12.7 million 871315
2023-03-31 13.7 million 856365
2022-12-31 14.7 million 1.1 million

XBIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -949634 70266
2023-06-30 -1.3 million 69389
2023-03-31 -1.1 million 68852
2022-12-31 -750907 118651

XBIO Net Income

No data available :(

XBIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 9.8 million - -
2023-06-30 10.7 million - -
2023-03-31 12.0 million - -
2022-12-31 13.1 million - -

XBIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.5 million
2023-06-30 1.5 million
2023-03-31 1.5 million
2022-12-31 14.2 million

XBIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.0 million 737241 -
2023-06-30 - 903243 945950 -
2023-03-31 - 595276 925743 -
2022-12-31 - 1.2 million 857167 -

XBIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 611174 -
2023-06-30 651005 -
2023-03-31 605844 -
2022-12-31 486972 -

XBIO

Price: $4.30

52 week price:
2.55
5.97

Earnings Per Share: -2.71 USD

P/E Ratio: -1.31

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 27600

Ebitda: -8.4 million

Market Capitalization: 6.8 million

Links: